Clinical trial NCT06436651: Digital Storytelling in Symptom Management Pediatric Oncology
Official title: Evaluation of the Effectiveness of Digital Storytelling Method in Symptom Method in Children With Oncological Problems
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Child, Only
Cancer
Symptoms and Signs
Narration
Keywords: child
cancer
nursing
symptom management
digital storytelling
Lead sponsor: Kocaeli University
Sponsor class: OTHER
Collaborators: name: Gazi University
First posted: 2024-05-31
Enrollment: 15
Sex: ALL
Minimum age (years): 7
Maximum age (years): 18
Standard ages: CHILD
ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: SUPPORTIVE_CARE

Brief summary: The aim of this clinical study is to evaluate the effectiveness of the digital storytelling method in symptom management in children diagnosed with oncology. It will also provide information about children's experiences with Digital Storytelling and the use of the method. The main questions it aims to answer are:

* Is there a difference between the anxiety scores of children who applied the Digital Storytelling Method and those who did not?
* Is there a difference between the fatigue scores of children who applied the Digital Storytelling Method and those who did not?
* Is there a difference between the nausea scores of children who applied the Digital Storytelling Method and those who did not?
* Is there a difference between the pain scores of children who applied and did not apply the Digital Storytelling Method?

Participants:

Complete the first stage data forms. Visit the clinic every 7-15 days for the digital storytelling process, which consists of 4 stages. After the storytelling process is completed, have a process evaluation meeting with the researcher.

Detailed description: Participants; Enterprise Group,

1. Interview (Week 1); Meeting the child, conducting a qualitative interview for needs analysis and introducing the forms
2. Interview (Week 2); Finding a digital story topic
3. Interview (Week 3); Writing a story on the specified topic
4. Interview (Week 4); Converting the story into digital form
5. Interview (Week 5); Showing the created story
6. Interview (Week 6); Conducting a qualitative interview regarding the digital storytelling process.

Each meeting will be held in 1-week periods. Primary outcome tools will be applied as pretest and posttest once in the 1st and 6th interviews, and twice in the other interviews.

Control Group;

1. Interview (Week 1); Meeting the child, introducing and applying the forms
2. Interview (Week 6); Conducting a qualitative interview regarding the digital storytelling process. Showing the videos prepared by the children in the initiative group. Application of primary outcome tools.

Eligibility criteria: Inclusion Criteria:

* 7-18 years old,
* Having received at least 1 cure of treatment,
* Completed the induction phase and is in the consolidation phase,
* Children who and their parents agree to participate in the study.

Exclusion Criteria:

* who cannot speak Turkish,
* Having a secondary chronic disease
* Having a second disease that will affect the cognitive process,
* Children/adolescents who cannot complete the 4 stages of the digital storytelling process.
* Children/adolescents who cannot complete the 4 stages of the digital storytelling process.
* Children/adolescents who take a break of more than 3 weeks between storytelling processes.

Primary outcomes:
measure: State-Trait Anxiety Inventory for Children
timeFrame: It will be used in the 1st and 6th interviews with the child (1st week-6th week).
measure: Visual Analogue Scale for Fatigue
timeFrame: It will be applied in all interviews with the child (6 interviews), before and after the interview. It will be applied 12 times in 6 weeks.
measure: The Baxter Retching Faces Scale
timeFrame: It will be applied in all interviews with the child (6 interviews), before and after the interview. It will be applied 12 times in 6 weeks.
measure: Wong-Baker FACES pain rating scale (WB-FACES)
timeFrame: It will be applied in all interviews with the child (6 interviews), before and after the interview. It will be applied 12 times in 6 weeks.
Secondary outcomes:
measure: SSPedi: Symptom Screening Scale in Pediatric Patients
timeFrame: It will be used in the 1st and 6th interviews with the child (1st week-6th week).
Other outcomes:
Locations:
city: Kocaeli
country: Turkey
facility: Kocaeli Universıty
state: İzmit
Study officials:
References: